mitoxantrone has been researched along with External Ophthalmoplegia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with acute myelogenous leukemia in relapse developed reversible bilateral lateral rectus muscle palsy and cerebellar dysfunction after receiving chemotherapy with high-dose cytosine arabinoside and mitoxantrone." | 3.67 | Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy. ( Castellanos, AM; Glass, JP; Keating, MJ; Ventura, GJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ventura, GJ | 1 |
| Keating, MJ | 1 |
| Castellanos, AM | 1 |
| Glass, JP | 1 |
1 other study available for mitoxantrone and External Ophthalmoplegia
| Article | Year |
|---|---|
Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy.
Topics: Adult; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Opht | 1986 |